Canada closing in on deal to get Stellantis battery plant back on track: Champagne
A deal to save a $5-billion electric vehicle battery plant in Windsor is inching closer, Industry Minister Francois-Philippe Champagne said Wednesday.
"I would say everyone should take a deep breath, things are going well, the negotiations are progressing," Champagne said following a Liberal caucus meeting in Ottawa.
"We're getting closer to the end of the negotiation."
The federal government, Ontario, Stellantis and LG Energy Solution have been in heavy negotiations for a few weeks after the companies paused construction on their planned factory in a dispute over federal subsidies.
The negotiations have been stuck between what Canada thinks is fair and affordable and what the company believes it is due. It has threatened to move the plant out of Windsor if it doesn't get what it says it was promised by the federal government in a "special contribution agreement" in February.
Champagne said the company has to be "reasonable."
The companies announced the plan for the battery facility in March 2022 with a $1-billion capital contribution from the federal and provincial governments.
But the companies went back for more government support after the United States announced new production tax credits for EV battery makers as part of the Inflation Reduction Agreement.
That legislation compelled Canada to sign an agreement with Volkswagen to subsidize batteries made at a planned new plant in St. Thomas, Ont., that could be worth up to $13 billion over a decade.
Champagne said he made a similar offer to Stellantis, but negotiations continue about how the formula would apply to the Stellantis plant, which is half the size of Volkswagen's but will start producing batteries three years earlier.
The subsidies are directly proportionate to the tax credits on offer under the IRA, which start at a tax credit of $35 per kilowatt hour from now until 2030, when they begin to be phased out. By 2033, they will be eliminated.
The Volkswagen deal includes a clause that ensures Canada's subsidies keep pace with the U.S. tax credits, and if the IRA is reduced or eliminated earlier than planned, Canada's subsidies will go down an equal amount.
The Stellantis plant is have an annual production capacity of 45 gigawatt hours, which could make enough batteries for more than 400,000 vehicles a year, with the first production happening as early as 2024.
Volkswagen's plant, with twice the production capacity, could produce enough for nearly a million vehicles annually, with initial production starting in 2027.
Neither company's plant is likely to make the maximum number of batteries in its first year.
In Canada, the production timelines would make Stellantis eligible for the full equivalent subsidy for nearly seven years, while Volkswagen would be getting it for just three or four.
Both plants are mainly intended to supply batteries to the companies' own EVs. For Volkswagen, those won't be made in Canada, as it has no auto plants in the country and no intention to build any.
Stellantis is retooling its auto manufacturing sites in both Windsor and Brampton, Ont., to be able to make electric vehicles. Champagne said stronger commitments, particularly for the Brampton plant, are part of the ongoing talks with the company right now.
"That's all part of the negotiation," he said.
Canada also insisted that the Ontario government put additional funds on the table, which Premier Doug Ford initially balked at but later committed to doing.
Champagne said he spoke with Ontario Premier Doug Ford both Tuesday and Wednesday.
“For me, this is an ongoing discussion," Champagne said. "We talk every day. And we're going to get to a deal. I'm very confident on that."
This report by The Canadian Press was first published May 31, 2023.
CTVNews.ca Top Stories

5 dead after single-vehicle crash near Swan River, Man.
Swan River RCMP are investigating a single-vehicle crash that killed five people in western Manitoba Saturday afternoon.
Two killed in bear attack at Banff National Park, grizzly euthanized: Parks Canada
Parks Canada says a bear attack in Alberta's Banff National Park has left two people dead. Officials say a response team trained in wildlife attacks was immediately mobilized but weather conditions at the time did not allow for helicopter use.
Ontario expands pharmacists' prescription powers to include 6 more common ailments
Ontario residents can now access treatment and medication for six more common ailments at pharmacies across the province.
Tim Wakefield, who revived his career and Red Sox trophy case with knuckleball, has died at 57
Tim Wakefield, the knuckleballing workhorse of the Red Sox pitching staff who bounced back after giving up a season-ending home run to the Yankees in the 2003 playoffs to help Boston win its curse-busting World Series title the following year, has died. He was 57.
Federal prisoner with terminal illness granted parole on compassionate grounds to die outside of jail
A terminally ill federal prisoner, who has been fighting for a compassionate release to die outside of jail, has been granted day parole.
Turkiye strikes suspected Kurdish militant targets in northern Iraq after suicide attack in Ankara
Turkish warplanes carried out airstrikes on suspected Kurdish militant targets in northern Iraq on Sunday following a suicide attack on a government building in the Turkish capital, Turkiye's defence ministry announced.
Quebec public-sector unions continue to see strong support for strike mandates
Members of several Quebec public-sector unions are continuing to vote in favour of strike mandates by large margins.
Chair hogs, dining divas and boorish boozers: Is cruising etiquette lost at sea?
When it comes to uncouth, uncultured and downright unacceptable behaviour on ships, experts in travel etiquette and cruising have seen it all. They share plenty of bad behaviours for passengers to avoid (and good ones they should emulate).
1 in 20 Americans used ivermectin, hydroxychloroquine to treat COVID-19, study finds
A recent study has found 1 in 20 people in the U.S. who contracted COVID-19 used non-evidence based treatment, such as ivermectin and hydroxychloroquine, due to beliefs in vaccine-related misinformation.